Merck (BSP:MRCK34) Net Interest Margin (Bank Only) %


BSP:MRCK34 Merck & Co Inc BSP:MRCK34
81 GF Score
Price R$81.15
GF Value R$77.19
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Merck Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BSP:MRCK34
81GF Score
Merck & Co Inc BSP:MRCK34
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (BSP:MRCK34) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of R$81.15 is trading 5.1% above its estimated GF Value™ of R$77.19. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for BSP:MRCK34:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: R$77.19 vs. price of R$81.15 (5.1% above fair value)
  • GF Score™: 81/100 with 8 warning signs

No single metric tells the full story. See the BSP:MRCK34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
81GF Score

Get the complete analysis for BSP:MRCK34

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$81.15
Price
R$77.19
GF Value